Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study

Netakimab is a humanised camelid-derived monoclonal antibody targeting interleukin-17A. Here, we report the results of post-hoc analysis of the ASTERA phase 3 study (NCT03447704, February 27, 2018) in patients with active radiographic axial spondyloarthritis (r-axSpA) grouped by baseline C-reactive...

Full description

Bibliographic Details

Published in:	Clinical and experimental rheumatology Vol. 41; no. 3; p. 718
Main Authors:	Mazurov, Vadim I, Dubinina, Tatiana V, Erdes, Shandor, Lapshina, Svetlana A, Soroka, Nikolay F, Kunder, Elena V, Smirnov, Alexandr V, Eremeeva, Anna V, Zinkina-Orikhan, Arina V, Morozova, Maria A, Gaydukova, Inna Z
Format:	Journal Article
Language:	English
Published:	Italy 01.03.2023
Subjects:	Axial Spondyloarthritis C-Reactive Protein Humans Inflammation - pathology Magnetic Resonance Imaging - methods Sacroiliac Joint - diagnostic imaging Sacroiliac Joint - pathology Sacroiliitis - diagnostic imaging Sacroiliitis - drug therapy Sacroiliitis - pathology Spondylarthritis - diagnostic imaging Spondylarthritis - drug therapy Spondylarthritis - pathology
ISSN:	0392-856X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!